THE EMMES COMPANY

Established in 2001, renewed in 2006, 2011, and 2017, and funded by the National Heart, Lung, and Blood Institute (NHLBI) and the National Cancer Institute (NCI), the BMT CTN infrastructure facilitates participation of a large network of centers in trials available to patients in all regions of the United States of America (US)... The Blood and Marrow Transplant Clinical Trials Network (BMT CTN) conducts multi-institutional clinical trials to evaluate promising cellular therapies for patients facing life-threatening disorders.

Also known as: BMT CTN, The Emmes Company, LLC